1.
Urol Clin North Am
; 15(1): 87-93, 1988 Feb.
Article
in English
| MEDLINE
| ID: mdl-3125645
ABSTRACT
The pharmacologic treatment of erectile failure is now a reality. However, current agents have major drawbacks. Some require invasive administration, whereas others offer only marginal effect. The use of hormones should be limited to well-documented cases of endocrine dysfunction. Oral and transcutaneous agents remain experimental, but new drugs are under investigation and show early encouraging results.